This book provides a comprehensive description of the global pharmaceutical industry along with its many public policy issues, both international and specific to the U.S. It presents basic economic analytical and empirical models useful for analyzing various aspects of pharmaceutical markets and drug policies. Coverage includes competition and market structure, the drug development process, pricing strategy, and post-marketing surveillance.